IL-37 suppresses CNS autoimmunity by increasing the frequency of Treg cells and reducing CD4 + T cell-derived IL-10 production
Reza Yazdani(Universal Scientific Education and Research Network), Abdolmohamad Rostami(Thomas Jefferson University), Hamed Naziri(Thomas Jefferson University), Bogoljub Ćirić(Thomas Jefferson University), Amir Moghadam Ahmadi(Thomas Jefferson University), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Jaya Aseervatham(National and Kapodistrian University of Athens), Mozhde Askari(Thomas Jefferson University), Guang-Xian Zhang(Thomas Jefferson University)
Cited by 7
Related Papers
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Primary immunodeficiency and autoimmunity: A comprehensive review
|Journal of Autoimmunity|2019|239